Loading...
Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study.
Perez-Cornago, Aurora; Appleby, Paul N; Pischon, Tobias; Tsilidis, Konstantinos K; Tjønneland, Anne; Olsen, Anja; Overvad, Kim; Kaaks, Rudolf; Kühn, Tilman; Boeing, Heiner; Steffen, Annika; Trichopoulou, Antonia; Lagiou, Pagona; Kritikou, Maria; Krogh, Vittorio; Palli, Domenico; Sacerdote, Carlotta; Tumino, Rosario; Bueno-de-Mesquita, H Bas; Agudo, Antonio; Larrañaga, Nerea; Molina-Portillo, Elena; Barricarte, Aurelio; Chirlaque, Maria-Dolores; Quirós, J Ramón; Stattin, Pär; Häggström, Christel; Wareham, Nick; Khaw, Kay-Tee; Schmidt, Julie A; Gunter, Marc; Freisling, Heinz; Aune, Dagfinn; Ward, Heather; Riboli, Elio; Key, Timothy J; Travis, Ruth C
Citations
Altmetric:
Series / Report no.
Open Access
Type
Article
Language
en
Date
2017-07-13
Research Projects
Organizational Units
Journal Issue
Title
Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study.
Translated Title
Published in
BMC Med 2017, 15(1):115
Abstract
The relationship between body size and prostate cancer risk, and in particular risk by tumour characteristics, is not clear because most studies have not differentiated between high-grade or advanced stage tumours, but rather have assessed risk with a combined category of aggressive disease. We investigated the association of height and adiposity with incidence of and death from prostate cancer in 141,896 men in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.